Calmark (Decision/Risk Analysis) Overview

  • Founded
  • 2007
Founded
  • Status
  • Public
  • Employees
  • 2
Employees
  • Stock Symbol
  • CALMA B
Stock Symbol
  • Share Price
  • $1.19
  • (As of Friday Closing)

Calmark (Decision/Risk Analysis) General Information

Description

Calmark Sweden AB provides tests for a newborn. The company's product Calmark's develops a patient-related diagnostic instrument (PNA), which makes it easier and faster to measure biomarkers for disease states in newborns. The company's PNA instrument consists of a reader and a disposable product that is placed in the reader when measured.

Contact Information

Website
www.calmark.se
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Decision/Risk Analysis
Other Industries
Medical Records Systems
Other Healthcare Technology Systems
Stock Exchange
SAT
Primary Office
  • Karlstad Innovation Park
  • Sommargatan 101A
  • 656 37 Karlstad
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Calmark (Decision/Risk Analysis) Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.19 $1.12 $0.53 - $1.77 296K

Calmark (Decision/Risk Analysis) Financials Summary

In Thousands,
USD
TTM 31-Dec-2017 FY 2017 31-Dec-2017 FY 2016 31-Dec-2016 FY 2015 31-Dec-2015
Revenue 14 79
EBITDA (320) (320) (189) (134)
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Calmark (Decision/Risk Analysis) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Calmark (Decision/Risk Analysis)‘s full profile, request access.

Request a free trial

Calmark (Decision/Risk Analysis) Executive Team (7)

Name Title Board Seat Contact Info
Anna Söderlund Chief Executive Officer
Sara Wili-Blomé Chief Financial Officer
Mathias Karlsson Ph.D Medical Advisor, Chairman & Co-Founder
You’re viewing 3 of 7 executive team members. Get the full list »

Calmark (Decision/Risk Analysis) Board Members (13)

Name Representing Role Since
Anna-Karin Edstedt Bonamy Ph.D Self Board Member 000 0000
Hans Risberg Self Board Member 000 0000
Kjersti Berg Marthinsen Self Board Member 000 0000
Lars Wingefors Wingefors Invest Board Member 000 0000
Lars-Olof Hansson Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Calmark (Decision/Risk Analysis) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial